C-UGBRmitochondria transplantation, gene therapy, cellular energy metabolism
0-100 chain-logic scale · 15 dimensions · scored on public evidence
cellvie mitochondria transplantation, gene therapy, cellular energy metabolism
cellvie is pioneering Therapeutic Mitochondria Transplantation, a treatment approach aimed at cellular energy metabolism. Its first application is ischemia-reperfusion injury, with an initial indication in kidney transplantation to reduce delayed graft function. The company is also developing a topical mitochondria-enabled gene therapy for Epidermolysis Bullosa by restoring Type VII Collagen expression.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
cellvie — Translational · Bottom quartile. Derived deterministically from 4 extracted project(s). Most-advanced status: phase 1. Band: translational. Modifiers: +5 modality breadth (2 modalities…
Source: Deterministic